To include your compound in the COVID-19 Resource Center, submit it here.

Moxy Drug-Coated Balloon: Completed Phase II enrollment

Bard's Lutonix technology center completed enrollment of 476 patients with diseased femoropopliteal leg arteries in

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE